Accelerating the path to full market potential
Full-Service Commercialization from Syneos Health enables biopharmaceutical companies to leverage our vast experience, insights, capabilities and global infrastructure with the goal of scaling-up, reducing risk and accelerating the path to full market potential.
Helping you increase the probability of commercial success
Early-stage biopharma companies have traditionally had limited options to get their first asset to market. In most cases, they pursue deals with larger partners and lose or limit rights to their asset or become a fully integrated company through heavy investment and a great deal of risk.
Thanks to our Full-Service Commercialization solution, there is now a third option: the leading integrated commercial delivery model. This model aims to increase efficiency, scale and speed by utilizing existing global infrastructure and significant expertise within Syneos Health and — importantly — enables customers to retain control of their assets longer to keep future options open.
Partnering with purpose to deliver integrated commercialization solutions to drive performance
We provide integrated pharmaceutical commercialization solutions designed around your own unique asset and corporate strategy. When you work with Syneos Health, our extensive commercialization capabilities – including award-winning, full-service agency capabilities – become yours. Together we build an agile and streamlined partnership that aims to create:
- Less complexity, less risk and a clear roadmap to commercial success grounded in a precise plan for all the variables unique to your asset
- Lower infrastructure investment and up to 20% savings by using a contract commercial model
- The ability to scale up or down to rapidly respond to market dynamics, opportunities or challenges
- The opportunity to expand the model across multiple assets over time, utilizing the same framework and a partner who understands your organization
- Customized, fully integrated solutions that bring deep therapeutic expertise, novel strategy and flawless execution
- A collaborative approach that provides unique access to data and experts to “read through the noise” in every therapeutic category
See how Full-Service Commercialization from Syneos Health helped these companies reach their potential:
Sound strategy coupled with tightly coordinated execution
We meet our customers exactly where they are in the commercialization process to create sound strategy coupled with tightly controlled execution – all with the highest levels of support from industry veterans who have been executive leaders in nearly every commercial function in biopharma.
We focus our integrated commercial solutions on your business objectives and design them to supplement your capabilities with a customized configuration of Syneos Health services. A Syneos Health Commercialization Asset Lead works in close collaboration with the commercialization lead in your organization, orchestrating all outsourced activity and gaining you targeted, efficient, cost-effective access to the full breadth and depth of Syneos Health resources and capabilities.
Full-Service Commercialization from Syneos Health is the commercial concierge emerging companies need that can help reduce risk, manage costs and optimize performance. Our hard-earned knowledge, agility and unrivaled expertise are our superpowers and, by extension, yours.
Reach out to learn more about how our Asset Development Team can customize an integrated commercialization solution for your unique asset.
Full-Service Commercialization is offered by Syneos One®
Syneos One is a dedicated interdisciplinary Asset Development Team that provides a set of tailored solution offerings that cover the full clinical development, medical affairs and commercialization continuum.